1. Home
  2. SCLX vs FRD Comparison

SCLX vs FRD Comparison

Compare SCLX & FRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$11.33

Market Cap

90.0M

Sector

Health Care

ML Signal

HOLD

Logo Friedman Industries Inc.

FRD

Friedman Industries Inc.

HOLD

Current Price

$19.61

Market Cap

140.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
FRD
Founded
2011
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Steel/Iron Ore
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
90.0M
140.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCLX
FRD
Price
$11.33
$19.61
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
75.9K
13.3K
Earning Date
11-14-2025
02-06-2026
Dividend Yield
N/A
0.82%
EPS Growth
N/A
43.48
EPS
N/A
1.63
Revenue
$40,360,000.00
$510,450,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$749.70
N/A
P/E Ratio
N/A
$11.90
Revenue Growth
N/A
8.72
52 Week Low
$3.60
$12.24
52 Week High
$34.27
$23.50

Technical Indicators

Market Signals
Indicator
SCLX
FRD
Relative Strength Index (RSI) 31.18 44.49
Support Level $11.10 $19.18
Resistance Level $13.83 $20.47
Average True Range (ATR) 0.99 0.67
MACD -0.02 -0.04
Stochastic Oscillator 8.28 19.19

Price Performance

Historical Comparison
SCLX
FRD

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About FRD Friedman Industries Inc.

Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.

Share on Social Networks: